- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Oral Intake of Glucosylceramide Improves Relatively Higher Level of Transepidermal Water Loss in Mice and Healthy Human Subjects
-
- Uchiyama Taro
- Functional Food Development Group, Functional Food Research & Development Center, Shiseido Co., Ltd. Research Center (Kanazawa-Hakkei)
-
- Nakano Yusuke
- Functional Food Development Group, Functional Food Research & Development Center, Shiseido Co., Ltd. Research Center (Kanazawa-Hakkei)
-
- Ueda Osamu
- Functional Food Development Group, Functional Food Research & Development Center, Shiseido Co., Ltd. Research Center (Kanazawa-Hakkei)
-
- Mori Hiroshi
- Functional Food Development Group, Functional Food Research & Development Center, Shiseido Co., Ltd. Research Center (Kanazawa-Hakkei)
-
- Nakashima Masaya
- Functional Food Development Group, Functional Food Research & Development Center, Shiseido Co., Ltd. Research Center (Kanazawa-Hakkei)
-
- Noda Akira
- Functional Food Development Group, Functional Food Research & Development Center, Shiseido Co., Ltd. Research Center (Kanazawa-Hakkei)
-
- Ishizaki Chiaki
- Shinjuku Minamiguchi Hifuka
-
- Mizoguchi Masako
- St. Marianna University School of Medicine
Bibliographic Information
- Other Title
-
- Oral intake of glucosylceramide improves relatively higher level of transdepidermal water loss in mice and healthy subjects
- Oral intake of glucosylceramide improves relatively high level of transepideramal water loss in mice and healthy human subjects
Search this article
Description
We examined the effect of oral intake of pure glucosylceramide derived from konjac extract on skin barrier function evaluated by transepidermal water loss (TEWL) in hairless mice with sodium dodecyl sulfate (SDS)-induced skin roughness. The difference of TEWL between SDS-treated site and untreated sites in the pure glucosylceramide-fed group was significantly lower than that in control group on day 14 of ingestion. We investigated interleukin-1α (IL-1α) production in the hairless mouse skin, and it was significantly lower in the glucosylceramide-fed group than that of control animals. This reduced IL-1α production should contribute to improvement of skin barrier function. To investigate the effect of oral intake of glucosylceramide in human, we conducted a randomized double-blind placebo-controlled study including 100 healthy subjects whose TEWL in cheek was relatively high. As a result, cheek TEWL was significantly lower in the test product group as compared with the control group in weeks 8 and 12 of ingestion (p=0.023 and p=0.002 respectively).
Journal
-
- Journal of Health Science
-
Journal of Health Science 54 (5), 559-566, 2008
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679475339008
-
- NII Article ID
- 110006935582
-
- NII Book ID
- AA11316464
-
- ISSN
- 13475207
- 13449702
-
- NDL BIB ID
- 9654962
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed